Progress in neuro-psychopharmacology & biological psychiatry
May 12, 2025
The zebrafish (Danio rerio) has emerged as a powerful organism in behavioral neuroscience, offering invaluable insights into the neural circuits and molecular pathways underlying complex behaviors. Although the knowledge of zebrafish behavioral reper...
Progress in neuro-psychopharmacology & biological psychiatry
May 2, 2025
BACKGROUND: For suicide in major depression disorder, it is urgent to seek for a reliable neuroimaging biomarker with interpretable links to molecular tissue signatures. Accordingly, we developed an ensemble learning scheme over transcriptome-defined...
Progress in neuro-psychopharmacology & biological psychiatry
Feb 25, 2025
Schizophrenia is a complex mental disorder. Accurate diagnosis and classification of schizophrenia has always been a major challenge in clinic due to the lack of biomarkers. Therefore, identifying molecular biomarkers, particularly in the peripheral ...
Progress in neuro-psychopharmacology & biological psychiatry
Dec 9, 2024
BACKGROUND: Craving is a core factor driving drug-seeking and -taking, representing a significant risk factor for relapse. This study aims to identify neuroanatomical biomarkers for quantifying and predicting craving.
Progress in neuro-psychopharmacology & biological psychiatry
Jun 18, 2024
BACKGROUND: Schizophrenia is a prevalent mental disorder, leading to severe disability. Currently, the absence of objective biomarkers hinders effective diagnosis. This study was conducted to explore the aberrant spontaneous brain activity and invest...
Progress in neuro-psychopharmacology & biological psychiatry
May 11, 2024
It is of vital importance to establish an objective and reliable model to facilitate the early diagnosis and intervention of internet gaming disorder (IGD). A total of 133 patients with IGD and 110 healthy controls (HCs) were included. We extracted r...
Progress in neuro-psychopharmacology & biological psychiatry
Nov 14, 2022
OBJECTIVE: To develop and validate artificial intelligence models for the prediction of cognitive impairment in chronic kidney disease (CKD) patients using structural and functional brain network.
Progress in neuro-psychopharmacology & biological psychiatry
Sep 28, 2022
Writing abilities are impacted by dysgraphia, a condition of learning disability. It might be challenging to diagnose dysgraphia at an initial point of a child's upbringing. Problematic abilities linked to Dysgraphia difficulties that is utilized in ...
Progress in neuro-psychopharmacology & biological psychiatry
Jul 18, 2022
The processing of negative emotions is closely related to the occurrence of depression, and improving the mood of patients with depression has an important effect on improving symptoms. This article applies deep learning to the diagnosis and treatmen...
Progress in neuro-psychopharmacology & biological psychiatry
Jul 5, 2022
In order to improve the psychological quality of athletes, this paper combines artificial intelligence technology to quantitatively analyze the psychological experience of athletes. Moreover, in view of the insufficiency of the ASI method to standard...